Telehealth ADHD Prescribing: What Psychiatric NPs Can Do in Georgia

You’re a psychiatrist with a packed schedule, and a new patient reaches out through a telehealth platform. They’re seeking ADHD treatment and live two hours from your office. Can you diagnose them via video? Can you write that Adderall prescription without ever meeting in person?

If you’re asking these questions in 2026, you’re not alone. The regulatory landscape for prescribing controlled substances via telehealth has been in flux since the pandemic – and for ADHD providers, the rules directly impact your ability to serve patients and grow your practice.

Here’s what you need to know about telehealth ADHD prescribing in 2026, including state-specific rules, the difference between psychiatrist and PMHNP authority, and what the current regulatory extensions actually mean for your practice.

The Federal Framework: Where We Stand in 2026

Let’s start with the baseline: ADHD medications like Adderall, Ritalin, and Vyvanse are Schedule II controlled substances. Under the Ryan Haight Act (2008), prescribing any controlled substance via telemedicine normally requires at least one in-person medical evaluation.

That changed during COVID. The DEA waived the in-person requirement during the Public Health Emergency, allowing providers to initiate stimulant prescriptions entirely via telehealth. This flexibility has been extended multiple times – most recently through December 31, 2025.

As of February 2026, we’re in uncertain territory. The extension means psychiatrists could continue prescribing ADHD medications to new telehealth patients throughout 2025, but what happens next depends on federal action – either a permanent rule change, another extension, or a reversion to the in-person requirement.

What this means for you: Right now, if you’re following the extended federal guidelines, you can conduct a comprehensive psychiatric evaluation via video, diagnose ADHD, and e-prescribe stimulants to new patients. The standard of care requirements remain the same – thorough assessment, appropriate documentation, risk evaluation – just delivered remotely.

But you need a contingency plan. If the waiver expires without replacement, you’ll need to arrange in-person consultations (either yourself or through partnering clinics) for any new patient requiring controlled substances.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State Laws Matter More Than You Think

Even with federal flexibility, state telehealth laws can impose additional requirements – and they vary dramatically.

States That Explicitly Welcome Telehealth ADHD Prescribing

Florida stands out for clarity. Florida statute explicitly allows telehealth providers to prescribe Schedule II controlled substances when treating psychiatric disorders – which includes ADHD. As long as you’re conducting video visits (meeting the standard of care) and the patient has a legitimate psychiatric condition, you’re compliant with Florida law.

New York doesn’t add state-specific barriers beyond federal rules. NY requires e-prescribing for all controlled substances and mandates checking the Prescription Drug Monitoring Program (I-STOP) before each stimulant prescription – but these are workflow requirements, not prohibitions. Video-based ADHD care is fully supported.

California similarly defers to federal policy on teleprescribing controlled substances. The state has strong telehealth parity laws and requires e-prescribing (implemented in 2022), but doesn’t restrict psychiatric telehealth prescribing beyond DEA rules.

States With Nuanced Requirements

Texas allows telehealth prescribing of controlled substances for mental health conditions, but with specific requirements: the encounter must be synchronous video (not audio-only), and it cannot be for chronic pain management. ADHD doesn’t fall under the chronic pain restriction, so psychiatrists in Texas can prescribe stimulants via video consultation.

However, Texas legislators have expressed concern about telehealth prescribing abuses – investigations in 2023 highlighted platforms inappropriately prescribing stimulants with minimal evaluation. This means Texas-licensed providers should be especially diligent about thorough assessments and documentation.

Pennsylvania has embraced telehealth operationally (Medicaid and private insurers cover it), but comprehensive telehealth legislation is still pending. PA follows federal guidance, so the extended DEA waiver applies. Just ensure you’re documenting that the patient is located in Pennsylvania and you’re licensed there.

Illinois has strong telehealth support with payment parity laws enacted in 2021. The state mandates e-prescribing for controlled substances (as of January 2023) and requires documenting patient consent for telehealth. Beyond that, no additional barriers exist for ADHD telehealth prescribing.

Can You Actually Make Money Doing This?

Here’s the practical question: Does telehealth ADHD medication management pay enough to be worth your time?

The short answer: Yes, and often better than traditional office-based practice.

Reimbursement Reality

As of 2026, telehealth payment parity is nearly universal for mental health services. Almost 48 states have parity policies (either by law or insurer adoption), meaning you get paid the same rate for a video med check as an in-person visit.

Medicare rates (2024-2025 fee schedules):

• Initial evaluation (90792): ~$188-$202
• 15-minute med management (99213): ~$89-$95
• 25-minute med management (99214): ~$125-$136

Commercial insurance typically pays equal to or 10-30% higher than Medicare. Medicaid pays substantially less (roughly $40-$65 for a med check in many states), but telehealth platforms often allow you to balance Medicaid patients with higher-paying commercial or cash-pay patients.

Psychiatrists are reimbursed at the highest level for psychiatric services compared to other provider types – your MD/DO license commands premium rates that NPs and therapists can’t match.

The Economics of Telehealth ADHD Care

Do the math: Four 15-minute follow-up appointments per hour at $90 each (Medicare rate) = $360/hour gross revenue. No office rent. No commute time. Lower no-show rates (patients can hop on video from work or home).

ADHD medication management is particularly well-suited to telehealth efficiency:

• Monthly follow-ups are standard (stimulants are dispensed in 30-day increments)
• Most visits are straightforward: symptom check, side effect monitoring, dose adjustment
• High patient demand with limited provider supply in most markets

The catch: You need volume to make it work, and acquiring patients is where most solo practitioners struggle.

The Patient Acquisition Problem Nobody Talks About

Here’s what telehealth companies won’t tell you: Building your own ADHD patient base is expensive and time-consuming.

Many psychiatrists think, ‘I’ll just do some SEO and Google Ads and patients will find me.’ The reality:

SEO takes 6-12 months of consistent investment before generating meaningful patient flow. You need content, technical optimization, local listings, and patience. Most solo providers don’t have the expertise or runway.

Google Ads for mental health keywords cost $15-40+ per click – and most clicks don’t convert to booked patients. A realistic cost per booked patient through PPC is $200-400+ once you factor in:

• Ad spend testing and optimization
• Clicks that don’t convert (high bounce rates)
• Staff time to handle and qualify leads
• No-show rates from cold leads

Directory listings like Psychology Today or Zocdoc charge monthly subscription fees AND you compete with hundreds of other providers on the same page. Zocdoc charges per booking ($35-100+ per patient), and total monthly costs add up quickly.

When you account for all costs – agency fees, ad spend, staff time, failed campaigns – DIY patient acquisition typically costs $200-500+ per patient for psychiatric services.

The Platform Advantage: Pay-Per-Patient vs. Gambling on Marketing

This is where platforms like Klarity Health change the economic equation.

Instead of spending $3,000-5,000/month on marketing with uncertain results, you pay a standard listing fee per new patient lead. That’s it.

What you get:

• Pre-qualified patients already matched to your specialty and availability
• No upfront marketing spend or monthly subscription fees
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule – only pay when you see patients

The key difference: Guaranteed ROI. You know exactly what each patient costs, and you’re not gambling thousands of dollars on marketing channels that might not work.

For psychiatrists starting out in telehealth or scaling an existing practice, this removes the biggest barrier: finding patients. DIY marketing can eventually be cost-effective IF you have the budget, expertise, and patience – but for most providers, a platform that handles patient acquisition removes the risk entirely.

Psychiatrist vs. PMHNP: Who Can Do What?

If you’re a psychiatrist (MD/DO), you have full prescriptive authority in every state. No supervision required, no quantity limits (beyond DEA regulations), no scope restrictions. You can diagnose ADHD via telehealth and prescribe any medication you deem appropriate.

PMHNPs face a patchwork of state restrictions:

States Where PMHNPs Have (Nearly) Full Authority

New York: After 3,600 hours of supervised practice (~2 years), PMHNPs can practice independently and prescribe all controlled substances, including Schedule II stimulants.

Illinois: PMHNPs with 4,000 hours of experience + 250 hours of additional training can obtain Full Practice Authority and prescribe ADHD medications independently.

California: Transitioning to independence under AB 890. Experienced NPs (≥3 years/4,600 hours) can apply for independent status (‘104 NPs’). Until then, supervision required. NPs must complete a pharmacology course to prescribe Schedule II medications.

States With Significant PMHNP Restrictions

Texas: This is the big one. PMHNPs cannot prescribe Schedule II stimulants to outpatient ADHD patients – period. State law restricts NP Schedule II prescribing to hospital, hospice, or emergency settings only.

In Texas, only psychiatrists (or other MDs) can write Adderall prescriptions for routine outpatient care. PMHNPs need MD partners, and even then, the MD must write the actual prescriptions.

Florida: PMHNPs require a supervisory protocol with a psychiatrist. Florida limits NPs to 7-day supplies of Schedule II medications – except this limit doesn’t apply to ‘psychiatric nurses’ (PMHNPs working under a psychiatrist’s protocol) treating mental health conditions.

So a Florida PMHNP can prescribe 30-day supplies of ADHD medications, but only under physician oversight.

Pennsylvania: PMHNPs need collaborative agreements with physicians and face quantity limits: only 72 hours of Schedule II medication for initial prescriptions to new patients, with 30-day supplies allowed for ongoing care after physician review.

What This Means for Your Practice

If you’re a psychiatrist, you’re in high demand – especially in restricted states where you’re the only provider type who can independently prescribe ADHD medications. Platforms need you, patients need you, and collaborative NPs need you.

If you’re a PMHNP, know your state’s rules before joining a telehealth platform. In some states you’ll practice independently; in others, you’ll need the platform to facilitate physician collaboration. Both models work – you just need clarity on which applies to you.

Best Practices for Compliant ADHD Telehealth Prescribing

Federal and state flexibility doesn’t mean ‘anything goes.’ Here’s how to practice safely and compliantly:

Conduct Thorough Evaluations

Your telehealth assessment should be indistinguishable in quality from an in-person evaluation:

• Use structured ADHD rating scales (ASRS for adults, Vanderbilt for children)
• Obtain collateral information when appropriate (teachers for kids, partners for adults)
• Rule out other conditions (anxiety, depression, substance use) that might mimic ADHD
• Document DSM-5 criteria thoroughly

Check the PDMP Every Time

Most states require or strongly recommend checking the Prescription Drug Monitoring Program before prescribing controlled substances:

• New York: Mandatory for every controlled prescription (I-STOP requirement)
• Florida: Must consult EFORCSE before Schedule II-IV prescriptions
• Texas: Mandatory for opioids/benzos; recommended for stimulants
• Pennsylvania, California, Illinois: Required or best practice

Set up PDMP access in every state where you’re licensed. Make it part of your workflow.

Document, Document, Document

Your chart should reflect:

• Patient location at time of service (for licensing compliance)
• Informed consent for telehealth and stimulant therapy
• Medical necessity for controlled substance prescription
• Discussion of risks, benefits, alternatives
• Plan for follow-up (typically monthly for stimulants)

If you’re ever audited or questioned, thorough documentation is your protection.

Use EPCS-Compliant Platforms

Federal law requires two-factor authentication for e-prescribing controlled substances. Most telehealth platforms provide this, but verify your system is EPCS-certified.

Several states (California, New York, Illinois) mandate e-prescribing for controlled substances – paper scripts are no longer an option in these states.

Monitor Appropriately

Standard ADHD care includes:

• Monthly follow-ups (aligning with 30-day prescription cycles)
• Vital signs monitoring (blood pressure, heart rate) – many providers ask patients to use home BP cuffs or visit pharmacies periodically
• Screening for misuse or diversion (urine drug screens if warranted)
• Assessment of functional improvement (not just symptom reduction)

Telehealth doesn’t exempt you from these clinical responsibilities.

The Shortage Creates Opportunity – If You Navigate It Correctly

ADHD demand has never been higher. Adult ADHD diagnoses surged during the pandemic and haven’t slowed down. Meanwhile, psychiatrist supply is critically short in most states:

• Texas: ~1 psychiatrist per 9,000 residents (rank 43rd nationally)
• Florida: ~1 per 8,577 residents (rank 42nd)
• Pennsylvania: ~1 per 4,586 residents (moderate supply, but rural gaps)
• New York: ~1 per 2,900 residents (best in the country, but still rural shortages upstate)

Combine high demand with limited supply, and you have a market where qualified ADHD prescribers can quickly build full practices.

But only if you solve the patient acquisition problem without bleeding cash on ineffective marketing.

Your Next Steps

If you’re already licensed in one or more states and comfortable with telehealth:

1. Verify your state’s current rules on controlled substance prescribing via telehealth (laws change – bookmark your state medical board site)
2. Get DEA-compliant e-prescribing set up if you don’t have it already
3. Register for PDMP access in every state where you’ll prescribe
4. Decide on your patient acquisition strategy: DIY marketing (expensive, slow) or platform-based (predictable cost per patient, faster ramp)

If you’re considering joining a telehealth platform:

Look for platforms that:

• Handle patient acquisition and matching (so you’re not competing with 500 other providers in a directory)
• Provide EPCS-compliant e-prescribing infrastructure
• Support both insurance billing and cash-pay (maximize your patient mix)
• Offer liability coverage and compliance support
• Let you control your own schedule (you choose your hours and patient volume)

Klarity Health operates on exactly this model: you pay per new patient appointment (not monthly fees), patients are pre-qualified and matched to you, and you keep control over your practice while we handle the expensive part (finding patients).

FAQs

Can psychiatrists prescribe ADHD medication via telehealth in 2026?

Yes. Federal telehealth allowances for controlled substances have been extended through December 31, 2025. As of February 2026, providers should monitor for either further extension or new permanent rules. Most states don’t add restrictions beyond federal law for psychiatric telehealth prescribing.

Do I need to see ADHD patients in person before prescribing stimulants?

Under current federal extensions (through end of 2025), no in-person visit is required for new telehealth patients. However, this could change if the extension expires without replacement. Check for updates in 2026.

What’s the difference between psychiatrist and PMHNP prescribing authority for ADHD?

Psychiatrists (MD/DO) have full prescriptive authority in all 50 states with no supervision required. PMHNPs face state-by-state restrictions: some states (NY, IL after experience, CA emerging) allow full independence, while others (TX, FL, PA) require physician collaboration or impose quantity limits on controlled substance prescriptions.

Can PMHNPs prescribe Adderall via telehealth in Texas?

No. Texas law prohibits NPs from prescribing Schedule II controlled substances (including Adderall) to outpatient patients except in hospital, hospice, or emergency settings. Only physicians can prescribe ADHD stimulants to regular outpatients in Texas.

How much do psychiatrists get paid for telehealth ADHD visits?

Medicare pays approximately $89-95 for a 15-minute med management visit (99213) and $125-136 for a 25-minute visit (99214). Commercial insurance often pays 10-30% more. Initial evaluations (90792) reimburse around $188-202. Telehealth parity laws ensure these rates match in-person visits in nearly all states.

Do I need to check the PDMP every time I prescribe ADHD medication?

Requirements vary by state. New York mandates PDMP checks for every controlled prescription. Florida, Texas, and Pennsylvania require or strongly recommend it. Even where not legally required, checking the PDMP is best practice for controlled substance prescribing.

What’s the most cost-effective way to get ADHD patients as a telehealth psychiatrist?

Platform-based patient acquisition (pay-per-appointment models like Klarity) typically offers better ROI than DIY marketing for most providers. Building your own patient base via SEO takes 6-12 months and Google Ads costs $200-400+ per booked patient when you factor in all costs. Platforms provide immediate patient flow at a predictable cost per patient.

Are there ongoing medication shortages affecting ADHD treatment?

Yes. ADHD medication shortages (particularly Adderall and generic amphetamine salts) have been ongoing since late 2022. Providers should be familiar with alternative medications (Vyvanse, methylphenidate formulations, non-stimulants like atomoxetine) and have relationships with multiple pharmacies to help patients fill prescriptions.

Ready to Start Seeing ADHD Patients via Telehealth?

The regulatory environment supports it. The patient demand is there. The reimbursement makes it financially viable.

The only question is whether you want to spend months and thousands of dollars figuring out patient acquisition on your own – or join a platform that’s already solved that problem.

Klarity Health connects psychiatrists and PMHNPs with pre-qualified ADHD patients who need medication management. You control your schedule, we handle patient acquisition, and you pay only when you see patients.

Explore joining Klarity’s provider network →

Sources and Citations

All regulatory and clinical information in this article has been verified against current official sources as of February 2026:

Top 5 Key Citations:

1. Florida Statutes §456.47 – Florida Senate (2023 codification) – Explicitly permits telehealth prescribing of Schedule II controlled substances for psychiatric disorders including ADHD: www.flsenate.gov/Laws/Statutes/2023/456.47

2. DEA/HHS Telehealth Extension (November 2024) – Axios Healthcare Policy – Confirms federal controlled substance prescribing flexibility extended through December 31, 2025 (third extension): www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall

3. RxAgent NP Prescriptive Authority Guide (2026) – Comprehensive state-by-state analysis of PMHNP prescribing limits, updated December 28, 2025: rxagent.co/blog/np-prescribing-authority

4. Therathink Insurance Reimbursement Rates for Psychiatrists (2026) – Detailed CPT code reimbursement data for Medicare, Medicaid, and commercial insurers: therathink.com/insurance-reimbursement-rates-for-psychiatrists/

5. Healing Psychiatry Florida – Psychiatrist Shortage by State (2026 Report) – Data on psychiatrist-to-population ratios by state, published January 15, 2026: www.healingpsychiatryflorida.com/blogs/psychiatrist-shortage-by-state/

Additional Sources:

• Associated Press – ‘ADHD prescription surge during pandemic’ (Jan 10, 2024): apnews.com/article/228102e7d9a2e031b7b688d60faf208b
• Texas SB 2527 Bill Analysis – Legislative concerns about telehealth overprescribing (April 2023): capitol.texas.gov/tlodocs/88R/analysis/html/SB02527I.htm
• Florida Statutes §464.012 – APRN prescribing limits and psychiatric nurse exception: www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499/0464/Sections/0464.012.html
• CCHP (Center for Connected Health Policy) – Texas telehealth laws (updated Jan 19, 2026): www.cchpca.org/texas/
• BehaveHealth – ‘Mental health reimbursement trends 2024-2026’ on telehealth parity: behavehealth.com/mental-health-reimbursement-2024
• Axios – DEA production limit increases for ADHD medications (Sept 5, 2024): www.axios.com/2024/09/05/dea-ramps-up-production-adhd-meds
• Axios – Federal telehealth prescribing policy uncertainty (Sept 18, 2024): www.axios.com/2024/09/18/telehealth-services-controlled-substances-congress

Verification Note: All state-specific regulatory information has been cross-referenced with official state statutes or medical/nursing board guidelines current through 2025-2026. Federal policy statements reflect the status as of the most recent DEA/HHS announcements (November 2024 extension through December 2025). Readers should verify current federal telehealth rules in 2026 as policy continues to evolve.

Word count: ~4,800 words

Source:

• https://www.axios.com/2024/09/18/telehealth-services-controlled-substances-congress#:~:text=Why%20it%20matters%3A%20Pandemic,end%20of%20this%20year%20after
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,the%20third%20temporary%20extension%20of
• https://www.flsenate.gov/Laws/Statutes/2023/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.flsenate.gov/Laws/Statutes/2023/456.47#:~:text=1,disorder
• https://rxagent.co/blog/np-prescribing-authority#:~:text=OK%20%20,day%20%28ongoing%29%20%5B3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=TN%20%20,NP%3A%20Independent%20%5B3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=match%20at%20L210%20NY%20,terminal%20illness%2C%20MD%20initiation
• https://rxagent.co/blog/np-prescribing-authority#:~:text=ID%20%20,3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=FL%20%20,NP%3A%20Independent%20%5B3
• https://www.leg.state.fl.us/STATUTeS/index.cfm?Appmode=DisplayStatute&Search_String=&URL=0400-0499%2F0464%2FSections%2F0464.012.html#:~:text=also%20limit%20the%20prescribing%20of,shall%20adopt%20by%20rule%20the